Filing Details

Accession Number:
0001225208-10-003477
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-04 12:00:00
Reporting Period:
2010-02-03
Filing Date:
2010-02-04
Accepted Time:
2010-02-04 11:51:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
901219 Human Genome Sciences Inc HGSI In Vitro & In Vivo Diagnostic Substances (2835) 223178468
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1191231 H James Davis 14200 Shady Grove Road
Rockville MD 20850
Exec. Vp, Gen Counsel & Sec. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-02-03 134,000 $12.56 212,040 No 4 M Direct
Common Stock Disposition 2010-02-03 134,000 $27.69 78,040 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option - Right to Buy Disposition 2010-02-03 134,000 $0.00 134,000 $12.56
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-04-07 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 12/9/09.
  2. This transaction was executed in multiple trades at prices ranging from $27.20 to $28.08. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
  3. These options have vested and are fully exercisable.